Sector
PharmaceuticalsOpen
₹61.91Prev. Close
₹60.7Turnover(Lac.)
₹7.43Day's High
₹62.89Day's Low
₹6052 Week's High
₹107.7952 Week's Low
₹51Book Value
₹15.75Face Value
₹10Mkt Cap (₹ Cr.)
374.67P/E
81.85EPS
0.75Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 61.03 | 61.03 | 61.03 | 61.03 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 29.51 | 21.24 | 9.61 | -12.62 |
Net Worth | 90.54 | 82.27 | 70.64 | 48.41 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 22.44 | 25.93 | 11.14 | 2.25 |
yoy growth (%) | -13.46 | 132.75 | 394.37 | 9.43 |
Raw materials | -0.03 | -0.5 | -0.79 | -1.66 |
As % of sales | 0.14 | 1.94 | 7.16 | 74.03 |
Employee costs | -6.49 | -5.76 | -5.06 | -3.02 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -1.21 | 4.4 | -11.85 | -21.69 |
Depreciation | -6.45 | -4.84 | -3.9 | -3.87 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.71 | -0.28 | 52.29 | -18.35 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.46 | 132.75 | 394.37 | 9.43 |
Op profit growth | -28.29 | -213.09 | -24.38 | 35.6 |
EBIT growth | -93.72 | -156.37 | -33.78 | 22.48 |
Net profit growth | -111.27 | -190.94 | -40.35 | 3.82 |
Particulars (Rupees in Crores.) | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 |
---|---|---|---|---|---|
Gross Sales | 6.57 | 6.01 | 8.22 | 13.46 | 13.19 |
Excise Duty | 0 | 0 | 0 | 0.62 | 0.82 |
Net Sales | 6.57 | 6.01 | 8.22 | 12.82 | 12.36 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.1 | 4.63 | 2.17 | 9.31 | 0.09 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Jignesh Anantray Goradia
Chairman (Non-Executive)
Azadar Hussain Khan
Independent Director
Chintan Jitendra Shah
Company Sec. & Compli. Officer
Abdul Gafoor Mohammad
Independent Director
JAGRUTI PRASHANT SHETH
Non Executive Director
Rakeshchandra Jagdishprasad Sinha
Additional Director
Premal Hemant Gandhi
S No 250-252 Turkapally Villag,
Shameerpet Mandal RR District,
Telangana - 500078
Tel: 91-40-23480430/0435
Website: http://www.zenotechlab.com
Email: abdul.gafoor@zenotech.co.in
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989 and changed to its present name effective on August 9, 2004. The Company is a pharmaceutical special...
Read More
Reports by Zenotech Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.